Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Gross Profit (2016 - 2025)

Historic Gross Profit for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$8.2 billion.

  • Sanofi's Gross Profit fell 24249.86% to -$8.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $38.2 billion, marking a year-over-year increase of 2317.51%. This contributed to the annual value of $38.0 billion for FY2025, which is 1310.04% up from last year.
  • According to the latest figures from Q4 2025, Sanofi's Gross Profit is -$8.2 billion, which was down 24249.86% from $29.5 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's Gross Profit registered a high of $34.7 billion during Q4 2023, and its lowest value of -$8.2 billion during Q4 2025.
  • Its 5-year average for Gross Profit is $9.8 billion, with a median of $8.1 billion in 2022.
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 33986.21% in 2023, then crashed by 24249.86% in 2025.
  • Sanofi's Gross Profit (Quarter) stood at $7.9 billion in 2021, then dropped by 0.77% to $7.9 billion in 2022, then surged by 339.86% to $34.7 billion in 2023, then plummeted by 83.47% to $5.7 billion in 2024, then plummeted by 242.5% to -$8.2 billion in 2025.
  • Its last three reported values are -$8.2 billion in Q4 2025, $29.5 billion for Q3 2025, and $8.8 billion during Q2 2025.